- Home
- KURA vs MUX Comparison
KURA vs MUX Comparison
Compare KURA & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- MUX
- Stock Information
- Founded
- KURA 2014
- MUX 1979
- Country
- KURA United States
- MUX Canada
- Employees
- KURA N/A
- MUX N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- MUX Precious Metals
- Sector
- KURA Health Care
- MUX Basic Materials
- Exchange
- KURA Nasdaq
- MUX Nasdaq
- Market Cap
- KURA 713.5M
- MUX 579.8M
- IPO Year
- KURA N/A
- MUX N/A
- Fundamental
- Price
- KURA $10.27
- MUX $18.33
- Analyst Decision
- KURA Strong Buy
- MUX Strong Buy
- Analyst Count
- KURA 13
- MUX 4
- Target Price
- KURA $25.00
- MUX $19.63
- AVG Volume (30 Days)
- KURA 1.9M
- MUX 2.0M
- Earning Date
- KURA 11-04-2025
- MUX 11-07-2025
- Dividend Yield
- KURA N/A
- MUX N/A
- EPS Growth
- KURA N/A
- MUX N/A
- EPS
- KURA N/A
- MUX N/A
- Revenue
- KURA $83,279,000.00
- MUX $168,169,000.00
- Revenue This Year
- KURA $68.63
- MUX $5.13
- Revenue Next Year
- KURA $141.59
- MUX $19.34
- P/E Ratio
- KURA N/A
- MUX N/A
- Revenue Growth
- KURA N/A
- MUX N/A
- 52 Week Low
- KURA $5.41
- MUX $6.38
- 52 Week High
- KURA $19.73
- MUX $24.88
- Technical
- Relative Strength Index (RSI)
- KURA 57.06
- MUX 49.45
- Support Level
- KURA $10.18
- MUX $18.28
- Resistance Level
- KURA $11.06
- MUX $19.80
- Average True Range (ATR)
- KURA 0.62
- MUX 1.24
- MACD
- KURA -0.02
- MUX -0.50
- Stochastic Oscillator
- KURA 60.35
- MUX 3.39
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About MUX McEwen Mining Inc.
McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.